Labcorp has launched an AI-powered real-world data platform in collaboration with Amazon Web Services (AWS) and Datavant to enhance Alzheimer’s disease research and drug development. This platform enables rapid analysis of large, de-identified healthcare datasets, significantly reducing the time traditionally required for data processing. By integrating various data sources, including diagnostic and genomic information, it aims to accelerate the identification of patient cohorts and treatment outcomes. The initiative aligns with Labcorp’s strategy to leverage AI for improving healthcare research, with plans for an initial validation phase to wrap up in spring 2026.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.digitalhealthnews.com/labcorp-launches-ai-real-world-data-platform-with-aws-to-speed-alzheimer-s-research-
